Skip to main content

Table 2 Basic demographical and clinical characteristics of participants

From: Quantification of prevalence, clinical characteristics, co-existence, and geographic variations of traditional Chinese medicine diagnostic patterns via latent tree analysis-based differentiation rules among functional dyspepsia patients

 

Hong Kong sample (n = 250)

Hunan sample (n = 150)

Age (years), mean (SD)

51.4 (13.0)

45.2 (13.7)

Female, n (%)

199 (79.6)

101 (67.3)

Body mass index (kg/m2), mean (SD)

20.8 (7.7)

22.1 (4.6)

Duration of symptoms (years), mean (SD)

3.6 (5.3)

2.3 (3.4)

Symptom subtype of functional dyspepsia

 Postprandial distress syndrome only

70 (28.0)

28 (18.7)

 Epigastric pain syndrome only

18 (7.2)

28 (18.7)

 Overlapping between two subtypes

162 (64.8)

94 (62.6)

Self-reported duration of symptoms, n (%)

 ≥ 5 years

57 (22.8)

18 (12.0)

 < 5 years

193 (77.2)

132 (88.0)

PHQ9 total scorea

 Mean (SD)

7.0 (4.9)

7.1 (6.4)

 Depression (cut-off 10), n (%)

67 (26.8)

51 (34.0)

GAD7 total scoreb

 Mean (SD)

5.8 (5.3)

6.6 (5.7)

 Anxiety (cut-off 10), n (%)

47 (18.8)

41 (27.3)

NDI results, mean (SD)

 Symptom severityc

44.8 (27.7)

53.6 (32.6)

 Eating/drinkingd

64.0 (23.2)

68.9 (24.4)

 Sleepd

62.9 (29.6)

67.8 (30.0)

 Knowledge/controld

70.2 (21.0)

67.7 (24.7)

 Interferenced

69.3 (20.0)

70.2 (21.7)

 Total QoL scored

66.6 (20.0)

68.6 (21.6)

With concomitant IBS diagnosise, n (%)

45 (18.0)

26 (17.3)

  1. GAD7 7-item generalised anxiety disorder scale, IBS Irritable bowel syndrome, NDI Nepean Dyspepsia Index, PHQ9 9-item patient’s health questionnaire, QoL Quality of life, SD Standard deviation
  2. aMaximum score = 27 with lower score indicating lower severity
  3. bMaximum score = 21 with lower score indicating lower severity
  4. cMaximum score = 195 with lower score indicating less symptom
  5. dMaximum score = 100 with higher score representing better quality of life
  6. eIBS was positive in this study when the following Rome IV criteria were fulfilled in the past three months at enrolment: (i) recurrent abdominal pain at least weekly; (ii) pain is associated with two or more of the following criteria: (a) at least 30% of occasions related to defecation; (b) at least 30% of occasions associated with a change in frequency of stool; or (c) at least 30% of occasions associated with a change in form (appearance) of stool; and (iii) symptom onset at least six months prior to diagnosis